YAP1-MAML2 fusion in a pediatric NF2-wildtype intraparenchymal brainstem schwannoma
Abstract Biallelic inactivation of NF2 represents the primary or sole oncogenic driver event in the vast majority of schwannomas. We report on a four-year-old female who underwent subtotal resection of a right medullary intraparenchymal schwannoma. RNA sequencing revealed an in-frame fusion between...
Main Authors: | Matthias A. Karajannis, Bryan K. Li, Mark M. Souweidane, Benjamin Liechty, JinJuan Yao, Jamal K. Benhamida, Tejus A. Bale, Marc K. Rosenblum |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | Acta Neuropathologica Communications |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40478-022-01423-7 |
Similar Items
-
Master regulator analysis of paragangliomas carrying SDHx, VHL, or MAML3 genetic alterations
by: John A. Smestad, et al.
Published: (2019-06-01) -
YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma
by: Jikai Zhao, et al.
Published: (2021-07-01) -
Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
by: Tianai Sun, et al.
Published: (2021-05-01) -
Poromas with YAP1–MAML2 fusions in a poromatosis case
by: Masako Yamamoto, MD, et al.
Published: (2022-07-01) -
Pediatric meningioma with a Novel MAML2-YAP1 fusion variant: a case report and literature review
by: Xuan Zheng, et al.
Published: (2022-12-01)